Early Infliximab Yields Superior Long-Term Effects on Linear Growth in Pediatric Crohn’s Disease Patients

Background/AimsInformation regarding the efficacy of early infliximab treatment in pediatric patients with Crohn’s disease (CD) is limited. We aimed to evaluate the impact of early combined immunosuppression on linear growth in pediatric patients with CD by performing step-up comparisons.Methods : T...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jaeyoung Choi, Ben Kang, Min-Ji Kim, Insuk Sohn, Hae Jeong Lee, Yon Ho Choe
Format:	Artigo
Idioma:	Inglês
Publicat:	Gastroenterology Council for Gut and Liver 2018-05-01
Col·lecció:	Gut and Liver
Matèries:	infliximab growth height tanner stage
Accés en línia:	http://gutnliver.org/journal/view.html?doi=10.5009/gnl17290
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!